Literature DB >> 7575553

Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages.

F Chen1, D C Kuhn, S C Sun, L J Gaydos, L M Demers.   

Abstract

In this report the differential regulation of NF-kappa B and nitric oxide (NO) was investigated in the mouse macrophage cell line RAW 264.7 following exposure to a mineral dust (silica) and/or an endotoxin (Lipopolysaccharide, LPS). The results indicated that silica and LPS can significantly induce the activation of NF-kappa B as well as elicit enhanced production of NO in RAW 264.7 cells as part of an early inflammatory response mechanism. A 24-hour time-course study showed that NO release from these cells continued to increase following the initial stimulus by LPS or silica. In contrast, activation of NF-kappa B was maximal at 6 hours and then showed a steady decline to 24 hours. The production of NO was suppressed by protease inhibitor and antioxidant, both of which block the activation of NF-kappa B. Surprisingly, the use of an NO synthase inhibitor resulted in an enhancement of NF-kappa B activation. These findings suggest that NO produced in macrophage cells in response to an inflammatory stimulus like silica or LPS my be linked to a negative feedback role on the activation of NF-kappa B.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575553     DOI: 10.1006/bbrc.1995.2363

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.

Authors:  Jing Yao; Di Pan; Yue Zhao; Li Zhao; Jie Sun; Yu Wang; Qi-Dong You; Tao Xi; Qing-Long Guo; Na Lu
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

2.  Protective effects of IL-4 on Bacillus Calmette-Guerin and lipopolysaccharide induced immunological liver injury in mice.

Authors:  Nan N Zhang; Nong Y Huang; Xi K Zhou; Xiao L Luo; Chang Y Liu; Yan Zhang; Ji Qiu; Yin B Zhang; Xiu Teng; Can Luo; Xian C Chen; Bing Kan; Yong Q Mao; Ai P Tong; Yu Q Wei; Jiong Li
Journal:  Inflamm Res       Date:  2011-09-24       Impact factor: 4.575

3.  The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappaB.

Authors:  X Shi; Z Dong; C Huang; W Ma; K Liu; J Ye; F Chen; S S Leonard; M Ding; V Castranova; V Vallyathan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

4.  Nitric oxide inhibits HIV tat-induced NF-kappaB activation.

Authors:  F Chen; Y Lu; V Castranova; Y Rojanasakul; K Miyahara; Y Shizuta; V Vallyathan; X Shi; L M Demers
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

5.  Nitric oxide up-regulates DNA-binding activity of nuclear factor-kappaB in macrophages stimulated with silica and inflammatory stimulants.

Authors:  J L Kang; K Lee; V Castranova
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

6.  Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol.

Authors:  S H Tsai; S Y Lin-Shiau; J K Lin
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Inhibition of NF-kappaB DNA binding by nitric oxide.

Authors:  J R Matthews; C H Botting; M Panico; H R Morris; R T Hay
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

8.  Regulation of ICAM-1 expression in mouse macrophages.

Authors:  A K Hubbard; C Giardina
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

Review 9.  NF-kappaB, a pivotal transcription factor in silica-induced diseases.

Authors:  Fei Chen; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production.

Authors:  Y W Kim; R J Zhao; S J Park; J R Lee; I J Cho; C H Yang; S G Kim; S C Kim
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.